Description
The identification of both opportunities and barriers to promote optimal pharmacologic care for individuals diagnosed with mental illness is key to successful health outcomes. This program is intended to identify both the barriers to care and opportunities to optimize pharmacotherapy that align with medications that have become newly available as well as the role of these agents in current guidelines.